JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. C. H.
Right arrow Articles by Anderson, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. C. H.
Right arrow Articles by Anderson, S. M.

J Biol Chem, Vol. 274, Issue 15, 10024-10034, April 9, 1999

Constitutive Activation of the Prolactin Receptor Results in the Induction of Growth Factor-independent Proliferation and Constitutive Activation of Signaling Molecules

Richard C. H. LeeDagger , Jay A. WaltersDagger , Mary E. Reyland, and Steven M. AndersonDagger

From the Dagger  Department of Pathology, School of Medicine, and  Department of Basic Science and Oral Biology, School of Dentistry, University of Colorado Health Sciences Center, Denver, Colorado 80262

The ability to induce the oncogenic activation of the human prolactin receptor (PRLR) was examined by deleting 178 amino acids of the extracellular ligand-binding domain. Expression of this deletion mutant in the interleukin-3 (IL-3)-dependent murine myeloid cell line 32Dcl3 resulted in the induction of growth factor-independent proliferation. Parental 32Dcl3 cells proliferated only in the presence of exogenous murine IL-3 (mIL-3), while 32Dcl3 cells transfected with the long form of the human PRLR were able to proliferate in response to mIL-3, ovine prolactin, or human PRL. Cells expressing the Delta 178 deletion mutant contained numerous phosphotyrosine-containing proteins in the absence of stimulation with either mIL-3 or ovine prolactin. Growth factor stimulation increased the number of proteins phosphorylated and the intensity of phosphorylation. These proteins included constitutively phosphorylated Janus kinase 2, signal transducer and activator of transcription 5, and SHC. Activated extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) were observed in unstimulated 32Dcl3 cells expressing the Delta 178 mutant. Likewise, transfection of Nb2 cells with the Delta 178 deletion mutant induced growth factor-independent proliferation and constitutive activation of Janus kinase 2, ERK1, and ERK2. In addition to the induction of a growth factor-independent state, the expression of the Delta 178 deletion mutant also suppressed the apoptosis that occurs when 32Dcl3 cells are cultured in the absence of growth factors such as IL-3. These data suggest that the constitutive activation of the PRLR can be achieved by deletion of the ligand binding domain and that this mutation leads to the oncogenic activation of the receptor as determined by the ability of the receptor to induce growth factor-independent proliferation of factor-dependent hematopoietic cells.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
C. Kedzia, L. Lacroix, N. Ameur, T. Ragot, P. A. Kelly, B. Caillou, and N. Binart
Medullary Thyroid Carcinoma Arises in the Absence of Prolactin Signaling
Cancer Res., September 15, 2005; 65(18): 8497 - 8503.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Li, K. G. Suresh Kumar, W. Tang, V. S. Spiegelman, and S. Y. Fuchs
Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCF{beta}-TrCP E3 Ubiquitin Ligase
Mol. Cell. Biol., May 1, 2004; 24(9): 4038 - 4048.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
I. Gourdou, J. Paly, C. Hue-Beauvais, L. Pessemesse, J. Clark, and J. Djiane
Expression by Transgenesis of a Constitutively Active Mutant Form of the Prolactin Receptor Induces Premature Abnormal Development of the Mouse Mammary Gland and Lactation Failure
Biol Reprod, March 1, 2004; 70(3): 718 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. B. Kline, M. A. Rycyzyn, and C. V. Clevenger
Characterization of a Novel and Functional Human Prolactin Receptor Isoform ({Delta}S1PRLr) Containing Only One Extracellular Fibronectin-Like Domain
Mol. Endocrinol., October 1, 2002; 16(10): 2310 - 2322.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Glasow, L.-C. Horn, S. E. Taymans, C. A. Stratakis, P. A. Kelly, U. Kohler, J. Gillespie, B. K. Vonderhaar, and S. R. Bornstein
Mutational Analysis of the PRL Receptor Gene in Human Breast Tumors with Differential PRL Receptor Protein Expression
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3826 - 3832.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. L. Schwertfeger, S. Hunter, L. E. Heasley, V. Levresse, R. P. Leon, J. DeGregori, and S. M. Anderson
Prolactin Stimulates Activation of c-jun N-Terminal Kinase (JNK)
Mol. Endocrinol., October 1, 2000; 14(10): 1592 - 1602.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
I. Olazabal, J. Muñoz, S. Ogueta, E. Obregón, and J. P. García-Ruiz
Prolactin (PRL)-PRL Receptor System Increases Cell Proliferation Involving JNK (c-Jun Amino Terminal Kinase) and AP-1 Activation: Inhibition by Glucocorticoids
Mol. Endocrinol., April 1, 2000; 14(4): 564 - 575.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.